Development of an inactivated vaccine candidate for SARS-CoV-2

Gao, Qiang, Bao, Linlin, Mao, Haiyan, Wang, Lin, Xu, Kangwei, Yang, Minnan, Li, Yajing, Zhu, Ling, Wang, Nan, Lv, Zhe, Gao, Hong, Ge, Xiaoqin, Kan, Biao, Hu, Yaling, Liu, Jiangning, Cai, Fang, Jiang, Deyu, Yin, Yanhui, Qin, Chengfeng, Li, Jing, Gong, Xuejie, Lou, Xiuyu, Shi, Wen, Wu, Dongdong, Zhang, Hengming, Zhu, Lang, Deng, Wei, Li, Yurong, Lu, Jinxing, Li, Changgui, Wang, Xiangxi, Yin, Weidong, Zhang, Yanjun, Qin, Chuan·2020·Science
DOI 10.1126/science.abc1932

Cited by (1,435)

Items 1,301–1,400 of 1,435

  1. Insight to SARS-CoV-2 Vaccines Based on Virus Structure and Properties
    Fatemah Salem Basingab, Kawther A. Zaher · 2021 · Pharmacophore
  2. Public Health Events Emergency Management Supervision Strategy Considering New Media and Citizen Participation
    Bingjie Lu, Lilong Zhu · 2022 · Research Square
  3. Covid-19 and Its Vaccine Development: A Narrative Review
    Risa Septinia, Didik Hasmono · 2021 · Jurnal Sains dan Kesehatan
  4. YENİ KORONAVİRÜS (COVİD-19) SALGINIYLA MÜCADELEDE MOLEKÜLER BİYOLOJİ VE GENETİK ÇALIŞMALARI
    Pervin Elvan Tokgün, Sude Dedeoğlu, Ayşe Gaye Tomatir · 2022 · Sağlık Bilimlerinde İleri Araştırmalar Dergisi / Journal of Advanced Research in Health Sciences
  5. Animal Models for SARS-CoV-2 research: Systematic Review of Literature and Future Directions
    Kabita Pandey, Arpan Acharya, Mahesh Mohan, Caroline Ng, Patrick Reid, Siddappa N. Byrareddy · 2020
  6. Novel Strategies of Immunization against COVID-19
    Aparajita Sen, Sunita Aggarwal, Shalini Sehgal, Nitika Nagpal, Aayushi, Anushka Joshi, Pranjal Saini, Radhika Chawla · 2022 · Journal of Pure and Applied Microbiology
  7. On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
    Lorena O. Fernandes-Siqueira, Fabiana Abdalla, Bruna G. Sousa, Nathane Cunha Mebus-Antunes, Thais Cristtina Neves-Martins, Fábio C. L. Almeida, Gustavo C. Ferreira, Didier Salmon, Luciana Serrão Wermelinger, Andrea Thompson Da Poian · 2022 · Research Square
  8. ChAdOx1 nCoV-19, BNT162b2 and CoronaVac Vaccines Do Not Induce as Strong Neutralising Antibodies with Broad Variant Protection as Infection and Suggest Vaccines that Induce Broader Sterilising Immunity are Essential to Stop the Pandemic
    Jia Xin Chua, Lindy G. Durrant, Yin Ling Chok, oi Ming Lai · 2022 · SSRN Electronic Journal
  9. Estudos sobre aspectos da resposta imune em infecções virais incluindo: proteção cruzada entre os vírus Chikungunya e Mayaro; análise de epítopos antigênicos da proteína E do vírus Zika; e avaliação da resposta à vacina inativada de SARS-CoV-2
    Marcílio Jorge Fumagalli · 2022 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  10. Cardiovascular protection in the pandemic and post-COVID-19 era
    Chunsong Hu · 2022
  11. Graphene-Derived Nanomaterials and Their Application in COVID-19 Related Prevention, Treatment, and Diagnosis
    Naorem Aruna Devi, Bibhu Prasad Swain · 2022 · Materials horizons
  12. Biotechnology strategies for the development of novel therapeutics and vaccines against the novel COVID-19 pandemic
    Kenneth H. Lundstrom · 2022 · Elsevier eBooks
  13. Assessment of the efficacy of SARS-CoV-2 vaccines in non-human primate studies: a systematic review
    Michel Jacques Counotte, Mariana Avelino de Souza Santos, Koert J. Stittelaar, Wim H. M. van der Poel, José L. Gonzáles · 2022 · Open Research Europe
  14. Ab Initio Electronic Dielectric “Constant” of Proteins: A Baseline for Electrostatic Interaction in Biomolecular Systems
    Puja Adhikari, Rudolf Podgornik, Bahaa Jawad · 2021 · ChemRxiv
  15. In Silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19
    Andrés López‐Cortés, Patricia Guevara‐Ramírez, Nikolaos C. Kyriakidis, Carlos Barba‐Ostria, Ángela León Cáceres, Santiago Xavier Guerrero, Cristian Robert Munteanu, Eduardo Tejera, Esteban Ortiz‐Prado, Doménica Cevallos-Robalino et al. · 2020 · ChemRxiv
  16. SARS-CoV-2 Biology Insights, Part IV.Antibody-Dependent Enhancement (ADE) and the tricky “Herd Immunity”: narrative review (Preprint)
    Laura Lafon-Hughes · 2020
  17. Assessing the Progress of Various Novel SARS-CoV-2 Vaccine Tests and Clinical Trials
    Yasmin Khajenoori, Ayesha Aslam-Mir, Arezoo Ahmadi · 2020
  18. Viewpoint SARS-CoV-2 Biology Suggests We Should Protect Our Young Population: state-of-the-art review (Preprint)
    Laura Lafon-Hughes · 2020
  19. SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges
    Balram Ji Omar, Arpana Singh, Vanya Singh, Ashish Kothari, Manju Ohri Pai · 2022 · Exploration of Immunology
  20. Safety and efficacy of COVID-19 Vaccines in special populations
    Sana Ghazi Alattas, Ibrahim M. Ibrahim, Ahmed S. Ali, Jehan Barakat, Assmaa A. Shaker, Tasneem Nawal Momen, Abir S. Mohamed, Abdalbabgi Alfadil, Amani E. Alharbi · 2022 · Journal of Contemporary Medical Sciences
  21. Design and assembly of plant-based COVID-19 candidate vaccines: reсent development and future prospects
    Elena A. Uvarova, Pavel A. Belavin, Е. В. Дейнеко · 2022 · Vavilov Journal of Genetics and Breeding
  22. Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model.
    Khalid Mahmoud El Sayed Zayed, Sherif Abdulaziz, Khaled Mohamed Ahmed M. Abdallah · 2022 · Research Square
  23. Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model
    Sherif Salah, Abdula Mubarki, Khalid Mahmoud El Sayed Zayed, Khaled Y Omar · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model.
    Khalid Mahmoud El Sayed Zayed, Sherif Abdulaziz, Abdullah Mubaraki, Khaled Mohamed Ahmed M. Abdallah · 2022 · Research Square
  25. Assessment of the effect of different covid 19 vaccines on liver enzymes for corona patients in Diyala governorate
    Hayder Nsiefe Jasim, Ameerah Mrebee Zarzoor · 2022 · International Journal of Health Sciences
  26. Evaluation of Serum Antibody Levels and Presence of Neutralizing Antibodies in Patients with Mild and Moderate Coronavirus Disease-2019
    Esra Özkaya, İlknur Tosun, Irmak Baran, Celal Kurtuluş Buruk, Neşe Kaklıkkaya, Faruk AYDIN, Murat ERTÜRK · 2022 · Mediterranean Journal of Infection Microbes and Antimicrobials
  27. Determination of COVID-19 PCR positivity and mutation status in coronaVacvaccinated individuals in Turkey
    AHMET ÇALIŞKAN, Mücahit Seçme, İlknur Kaleli̇, Tuğba Sarı, Sedef Zeliha Öner, SANİYE KÜÇÜKAKIN YAKA, Büşra Dönmez · 2022 · TURKISH JOURNAL OF MEDICAL SCIENCES
  28. COVID-19 Disease
    Christopher P. Conlon, John D. Firth · 2020
  29. Immune Response and Antibody-Dependent Mechanism Against Viral Infections: SARS-CoV-2 Vaccine as a Case Study
    Abolaji Samson Olagunju, John Oluwafemi Teibo, Olayinka Anthony Ad, Opeyemi Abigail Akinfe, Olaide Damilola Olagoke · 2022 · Journal of Pharmacology and Toxicology
  30. Utilizing the K18-hACE2 mouse model to develop protective COVID-19 vaccines
    Ting Y. Wong · 2022 · The Research Repository @ WVU (West Virginia University)
  31. Sindrom Guillain-Barre sebagai Gejala COVID-19 dan Potensi Efek Samping Pasca-Vaksinasi COVID-19
    Joanesa Della Felista, Budi Riyanto Wreksoatmodjo · 2022 · Cermin Dunia Kedokteran
  32. Latest in COVID-19 Vaccine 'Candidates' Race
    Manar Fayiz Mousa Atoum, Dalia Abu Zreig, Laith Majed Abu Zreig · 2022 · Infectious Disorders - Drug Targets
  33. Current Status of Vaccines Developed for SARS-CoV-2 Infection: A Review
    Carlos Andrés Marín Hoyos, Jean Paul Cappellaro Sánchez, Romel F Gómez, Monica Chavez Vivas · 2022 · Bangladesh Journal of Infectious Diseases
  34. Studies on the enzymatic specificity of diguanylate cyclases domains and the production of new second messengers
    Santiago Justo Arévalo · 2022 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  35. Inactivated Vaccines and Recombinant Protein
    Patric U. B. Vogel · 2022 · Essentials
  36. Inhalable SARS-CoV-2 vaccines for single-dose dry-powder aerosol immunization and orchestrated mucosal/systemic immune responses
    Tong Ye, Zhouguang Jiao, Xin Li, Zhanlong He, Yanyan Li, Fengmei Yang, Xin Zhao, Youchun Wang, Weijin Huang, Meng Hua Qin et al. · 2022 · Research Square
  37. Nanotechnology in COVID-19 Vaccines
    Ananya Jain, Shilpa Sharma · 2022
  38. Similarities and Differences Between Feline Infectious Peritonitis and COVID-19: Traditional Review
    Mutlu Sevinç, Mahmut Ok, Merve İder · 2022 · Turkiye Klinikleri Journal of Veterinary Sciences
  39. COVID-19 Vaccination in India
    Sadhan Kumar Ghosh, Anjan Adhikari, Anirudhha Mukhopadhyay, Samprikta Bose, Komal Sharma · 2022 · Springer eBooks
  40. Ethnological aspects of COVID-19
    Priya Dhiman, Meenakshi Bhatia · 2022 · Brazilian Journal of Pharmaceutical Sciences
  41. La Ciencia detrás de la vacunas contra SARS CoV-2
    E. J. Gutiérrez-Ruiz, Roger Iván Rodríguez‐Vivas, J.A. Rosado-Aguilar, Eduardo Gutiérrez‐Blanco, Manuel Emilio Bolio‐González · 2022 · Bioagrociencias
  42. The Rationale Behind the Effectiveness of COVID-19 Vaccines and Associated Immunological Mechanisms
    Sami El Khatib · 2022 · Turkish Journal of Immunology
  43. Peer Review #1 of "The long-term dynamics of serum antibodies against SARS-CoV-2 (v0.1)"
    2022 · PeerJ
  44. Peer Review #2 of "The long-term dynamics of serum antibodies against SARS-CoV-2 (v0.1)"
    2022 · PeerJ
  45. Peer Review #3 of "The long-term dynamics of serum antibodies against SARS-CoV-2 (v0.1)"
    2022 · PeerJ
  46. Peer Review #3 of "The long-term dynamics of serum antibodies against SARS-CoV-2 (v0.2)"
    2022 · PeerJ
  47. Peer Review #1 of "The long-term dynamics of serum antibodies against SARS-CoV-2 (v0.2)"
    2022 · PeerJ
  48. Comparison of SARS-CoV2 IgG Antibody Levels in Health Workers with and without a History of COVID-19 Infection after Heterologous Vaccination at Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
    Ferda Puspalina, Nova Kurniati, Eddy Mart Salim, Yuniza, Zen Ahmad · 2023 · Bioscientia Medicina Journal of Biomedicine and Translational Research
  49. Comparison of Post Vaccination Antibody Levels for Coronavirus Disease 2019 (COVID-19) between Survivors and Non-Survivors of COVID-19
    Yuniza, Nova Kurniati, Zen Ahmad · 2023 · Bioscientia Medicina Journal of Biomedicine and Translational Research
  50. Development and characterization of a multimeric recombinant protein based on the spike protein receptor binding domain of SARS-CoV-2 that can neutralize virus infection
    Veronica Aparecida de Lima, Rodrigo da Silva Ferreira, Maria Luiza Vilela Oliva, Robert Andreata‐Santos, Luiz Mário Janini, Juliana Terzi Maricato, Milena Apetito Akamatsu, Paulo Lee Ho, Sérgio Schenkman · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Post COVID-19 - Effects on Human Health
    Nicolás Padilla-Raygoza · 2023 · IntechOpen eBooks
  52. Evaluation of Adverse Effects due to Inactive COVID-19 Vaccination in Healthcare Workers with or without a History of COVID-19
    Gamze Kalın Ünüvar, Zeynep Türe, Hüseyin Nadir Kahveci, Orhan Yıldız, Bilgehan Aygen · 2023 · Klimik Dergisi/Klimik Journal
  53. İzmir'de Bir Aile Sağlığı Merkezinde Covid-19 Aşısı Uygulanan Kişilerde Yan Etki Profilinin İncelenmesi
    Esra OKUMUŞ, Özge Tuncer, Selma Yegane Tosun · 2023 · Turkish Journal of Family Medicine & Primary Care
  54. Research Advances in SARS-Cov-2 Vaccination of Bell’s Palsy
    怡 余 · 2023 · Advances in Clinical Medicine
  55. Immune System Mechanism and Vaccination of SARS-Cov-2
    Yukyu Chan, Yihan Hua · 2023 · Highlights in Science Engineering and Technology
  56. Impact of COVID-19 Vaccines on Cirrhotic Egyptian Patients: A Prospective Cohort Study
    2023 · Al-Azhar University Journal of Virus Researches and Studies
  57. In-Silico Study of Virus-Host Protein-Protein Interactions (PPIs) can Anticipate and Cure Viruses by Reducing Time-Duration of Vaccine Trials: A Review
    2023 · Current Research in Vaccines Vaccination
  58. Animal Pre-Clinical Study of an Inactivated SARS-CoV-2 Vaccine candidate (Osvid-19 ®): Immunogenicity, Protective, and Safety Aspects
    2023 · Journal of Population Therapeutics and Clinical Pharmacology
  59. Molecular mechanism study of the structural regulation of the N-terminal domain binding antibody on the receptor binding domain of SARS-CoV-2
    Hongtao Liu, Zihui Tian, Shuai Yuan, Shuangyan Zhou · 2023 · Physical Chemistry Chemical Physics
  60. The influence of SARS-CoV-2 vaccination on 28-day mortality and hospitalization rate of COVID-19 patients under 40 years
    Erdınc Koca, Sevgi Kutlusoy, Ahmet Baris Aydin, Umut Sabri Kasapoğlu · 2023 · Turkish Journal of Science and Health
  61. RESPOSTA SOROLÓGICA EM PVHIV E INDIVÍDUOS SEM HIV VACINADOS CONTRA O SARS-CoV-2
    Larissa Schneider Cafardo, Marisa Ailin Hong, Luís Fernando de Macedo Brígido · 2023
  62. Anxiety and Association with COVID-19 Vaccination-Related Headache Symptoms
    Zeynep Tuncer, Oğuzhan Kılınçel, Şenay Kılınçel, Pelin Göksel, Miraç Barış Usta · 2023 · Acta Medica Nicomedia
  63. COVID-19 Pandemic and the Global Vaccine Strategy
    Anita Yadav, Neerja Kapoor, Shivji Malviya · 2019 · THE SCIENTIFIC TEMPER
  64. Immunities Specific to Both of the M Protein Ectodomain and RBD Synergize to Confer Cross-protection against SARS-CoV-2 Infections
    Yibo Tang, Kaiming Tang, Yunqi Hu, Zi‐Wei Ye, Wanyu Luo, Cuiting Luo, Hehe Cao, Ran Wang, Dejian Liu, Cuicui Liu et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Neutralizing antibody responses assessment after vaccination in People Living with HIV in the Republic of the Congo
    Armel Landry Batchi-Bouyou, Jean Claude Djontu, Line Lobaloba Ingoba et al. · 2023 · Research Square
  66. Local and systemic side effects of the coronanovac vaccine
    Ayşe Karaoğullarından, Sanem Okşan Erkan, Birgül Tuhanioğlu, İlhami Yıldırım, Asena Ayça Özdemir · 2023 · Interdisciplinary Medical Journal
  67. Inhalable SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
    Tong Ye, Zhouguang Jiao, Xin Li et al. · 2023 · Research Square
  68. Difficulties and Barriers in Accomplishment of HFA 2000
    Hilary H. L. Yee, Vincent Law · 2023 · Springer eBooks
  69. Development of plant-produced subunit vaccines to elicit the immunogenicity against SARS-CoV-2 variant viruses
    Narach Khorattanakulchai, Waranyoo Phoolcharoen · 2022
  70. Development of plant-produced subunit vaccine and therapeutic protein for COVID-19
    Konlavat Siriwattananon · 2021 · Chula Digiverse
  71. Post-COVID Vaccination Hearing Disorder
    Denis Anugrah Oktrivianto, Sally Mahdiani, Yussy Afriani Dewi · 2023 · Advances in health sciences research/Advances in Health Sciences Research
  72. COVID-19 Vaccination Effectively Reduces Pneumonia Severity as Assessed by Routine Chest Computed Tomography
    2023 · Medical & Clinical Research
  73. To Concern or Not to Concern: Analyses of Perception and Attitudes toward COVID Vaccine’s Side Effect among the Philippines and Malaysians (Preprint)
    Roy Rillera Marzo, Mengieng Ung, Edlaine Faria de Moura Villela, Shekhar Chauhan, Mark Mohan Kaggwa, Mohammed Musfer Aljuaid, Michael Head, Tahani Mohammed Ameen Alrahbeni, Khalid Al‐Mugheed, Tin Tin Su · 2023
  74. Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
    Lucia Inchauste, Elif Nurtop, Lissete Bautista Machicado, Yanine Leigue Roth, Shirley Lenz Gonzales, Maria Luisa Herrera, Katty Mina Villafan, Pedro Mamani Mamani, Marcelo Ramos Espinoza, Juan Carlos Pavel Suarez et al. · 2025 · eLife
  75. Different COVID-19 mRNA-based Vaccine Platforms as The Booster Dose and Their Impact on Omicron: A Literature-Based Overview
    Bagus Aulia Mahdi, Gatot Soegiarto, Laksmi Wulandari, Dewajani Purnomosari · 2023 · Indonesian Journal of Tropical and Infectious Disease
  76. COVID-19 Vaccines
    Sibel Yıldız Kaya, Abdurrahman Kaya, Bilgül Mete · 2023 · Cam and Sakura Medical Journal
  77. Social Interactions and Relationships: Covid-19 Pandemic and the Emergence of the New Normal During the Lockdown in Universities in Nigeria
    2023 · International Society for the Study of Vernacular Settlements
  78. Factors influencing vaccination against SARS-CoV-2 among patients with inflammatory bowel disease
    Xinying Wang · 2023
  79. Safety and immunogenicity of CoronaVac in healthy adults: A prospective observational multicenter real-world study in Henan Province, China
    Benchen Rao, Ling Wang, Mengzhao Yang et al. · 2024 · Virulence
  80. Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
    Lucia Inchauste, Elif Nurtop, Lissete Bautista Machicado, Yanine Leigue Roth, Shirley Lenz Gonzales, Maria Luisa Herrera, Katty Mina Villafan, Pedro Mamani Mamani, Marcelo Ramos Espinoza, Juan Carlos Pavel Suarez et al. · 2024 · eLife
  81. Improving SARS-CoV-2 variants monitoring in the absence of genomic surveillance capabilities: a serological study in Bolivian blood donors in October 2021 and June 2022
    Lucia Inchauste, Elif Nurtop, Lissete Bautista Machicado, Yanine Leigue Roth, Shirley Lenz Gonzales, Maria Luisa Herrera, Katty Mina Villafan, Pedro Mamani Mamani, Marcelo Ramos Espinoza, Juan Carlos Pavel Suarez et al. · 2024 · eLife
  82. Risk prediction for severe COVID-19 progressing to critical illness and death in the ICU and efficacy analysis of using traditional Chinese medicine
    Wenyi Tang, Bo Ye, Lina Zhou · 2024 · Medicine
  83. Ischemic and Inflammatory Ocular Adverse Events Following Different Types of Vaccination for COVID-19 and Their Incidence Analysis
    Eoi Jong Seo, Moon Sun Jung, Ki‐Bum Lee · 2024 · Korean Journal of Ophthalmology
  84. Application of the Crystal Structure of the SARS-CoV-2 Spike Protein for the Development of a Peptide Vaccine against Virus
    A. S. Ivanovsky, I. A. Kolesnikov, Yu. V. Kordonskaya · 2023 · Кристаллография
  85. Assessing the impact of COVID-19 inactivated vaccination doses on male fertility i n assisted insemination with husband's sperm (AIH) cycle
    Yating Sun, Luyun Zhang, Jia Yao · 2024 · Research Square
  86. Persistence of Antibody Response Against SARS-CoV-2 After Vaccination
    Heri Setiyo Bekti, Nur Habibah, I Gusti Agung Ayu Dharmawati, Fusvita Merdekawati, Ganjar Noviar · 2023 · JURNAL INFO KESEHATAN
  87. Effectiveness of inactivated and mRNA COVID-19 vaccines on sperm parameters
    Muhamet Afşin, Ömer Acer, Dilek Yavuz · 2024 · Dicle Medical Journal / Dicle Tip Dergisi
  88. Exploring the promise of COVID-19 vaccines: A review of preclinical studies
    Shubham Adhikary, Harpal Singh Buttar, Hardeep Singh Tuli, Ginpreet Kaur · 2024 · Elsevier eBooks
  89. COVID-19 vaccines and their impact: An overview
    Ka-Wa Khong, Ivan Fan‐Ngai Hung · 2024 · Elsevier eBooks
  90. Detecção de anticorpos IgG e anticorpos totais neutralizantes para variantes de preocupação de SARS-CoV-2 em indivíduos sadios após vacinação para COVID-19
    Almir Ribeiro da Silva · 2024 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  91. Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations
    Deepika Kumari, Anil Kumar Mavi, Jyoti S Chaudhary, Manoj Kumar, Rajesh Kumar Gupta, Umesh Kumar · 2024 · Defence Life Science Journal
  92. Opportunities, Challenges in Translational Vaccine Research: Lesson Learnt from Vaccine Development During the CoVID-19 Pandemic
    Sudhanarayani S. Rao, Vignesh Sounderrajan, T. Thangam, Krupakar Parthasarathy · 2024 · Springer eBooks
  93. Outbreak of Deadly Coronavirus (COVID-19) Pandemic: Diagnosis and Management
    Ankit Tiwari, Divyanshu Singh, Dharmendra Kumar, Vikas Chandra, Naveen Kumar Vishvakarma, Dhananjay Shukla, Harit Jha, Rajat Pratap Singh · 2024 · Springer eBooks
  94. Investigation on the effect of age and gender variables on SARS-CoV-2 in persons applying to a hospital in İstanbul
    Devran Şener, Zeynep Kolören, Ülkü Karaman, Yeliz Kaşko Arıcı · 2024 · MIDDLE BLACK SEA JOURNAL OF HEALTH SCIENCE
  95. Evaluation of the effectiveness of chemical inactivation and immunogenicity of the Omicron variant of the SARS-CoV-2 virus
    Г.А. Жаппарова, Balzhan Sh. Myrzakhmetova, T. M. Tlenchiyeva, Aiganym A. Tussipova, K.B. Bissenbayeva, Aizhan S. Toytanova, Кутумбетов Леспек Бекболатович · 2024 · Problems of Virology
  96. COVID-19 Vaccine Manufacturing Processes: Making the Molecules to Solve the Pandemic
    Jennifer A. S. Romine, Stephen A. Kolodziej, Tarl Vetter, Michael P. Dux · 2024 · Springer eBooks
  97. Nanotheronostics: Part II
    Sikandar Shaikh · 2024 · Springer eBooks
  98. SARS-CoV-2 Delta Variant Spike Protein: Structure, Mechanism, and Docking Interaction with Antiviral Ligands from the Plants of the Phyllanthus Genus
    Ashokkumar Sibiya, Baskaralingam Vaseeharan, Palaniappan Ramasamy, Sundaresan Bhavaniramya · 2024 · Coronaviruses
  99. Study of the immunogenicity, efficacy and safety of recombinant RBD SARS-CoV-2 vaccine with CpG adjuvant in rodent, non-rodent and Maccaca fascicularis using Indonesian Strain Virus
    Nur Amalia Limeilati, Reviany V. Nidom, Trilokita Tunjung Sari, Nurvita Putih Kusumarahayu, Siti V. Fransiska, Setyarina Indrasari, Afrillia Nuryanti Garmana, Dhyan K. Ayuningtyas, Gembong S. Nugroho, Darsono Darsono et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Hybrid polymeric systems for potential applications in vaccine delivery
    Emma Alisa Kean, Oluwatoyin A. Adeleke · 2025 · Elsevier eBooks